Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial
Authors:
- D. CellaDCD. Cella
- A.S. PickardAPA.S. Pickard
- M.S. DuhMDM.S. Duh
- A. GuerinAGA. Guerin
- N. MishaginaNMN. Mishagina
- L. AntràsLAL. Antràs
- M.P. NearyMNM.P. Neary
- L. McCannLML. McCann
- R. HodgeRHR. Hodge
- C.N. SternbergCSC.N. Sternberg
- 1 February 2012
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 48 (3) , 311-323
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III TrialJournal of Clinical Oncology, 2010
- Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomesCancer Treatment Reviews, 2009
- Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal CancerThe Oncologist, 2008
- Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized TrialJournal of Clinical Oncology, 2008
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- Effects of Sorafenib on Symptoms and Quality of LifeAmerican Journal of Clinical Oncology, 2007
- Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell CarcinomaJournal of Clinical Oncology, 2006
- Applying Survival Data Methodology to Analyze Longitudinal Quality of Life Data2002
- Interpreting the significance of changes in health-related quality-of-life scores.Journal of Clinical Oncology, 1998
- Modeling Valuations for EuroQol Health StatesMedical Care, 1997